Venetoclax,Azacitidine
Roche,Abbvie
['leusm']
#asco23 #leusm lai: benefit from aza/ven therapy associated with mutational profile (best if wt for tp53, flt3 and aras; worst if tp53mut). ivo with hma an option in 1l. 
Assoc Professor, UCSF hematology/BMT. Translational researcher interested in leukemia, MDS, MRD, post-HCT relapse, GVHD, & immune recon. Photos: pyknosis (IG)